Trial Profile
A Prospective, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Parallel-Group Study of Intranasal Amphotericin B Suspension in Patients With Refractory, Postsurgical Chronic Sinusitis (CS)
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 04 Jun 2014
Price :
$35
*
At a glance
- Drugs Amphotericin B (Primary)
- Indications Chronic sinusitis
- Focus Therapeutic Use
- Sponsors Accentia Biopharmaceuticals
- 04 Jun 2014 New trial record